Advani, A., Chen, L., Sun, Z., Mattison, R., Paietta, E., Zhang, Y., Racevskis, J., Lazarus, H., Rowe, J., Arber, D., Wieduwilt, M., Liedtke, M., Bergeron, J., Wood, B., Pratz, K., Dinner, S., Frey, N., Gore, S., Bhatnagar, B., Atallah, E., Uy, G., Jeyakumar, D., Lin, T., Willman, C., Podoltsev, N., Deangelo, D., Patel, S., Elliott, M., Tzachanis, D., Vachhani, P., Bhave, R., Sharon, E., Little, R., Erba, H., Stone, R., Luger, S., Mullighan, C., Tallman, M., Litzow, M. (2025). Toxicities on the E1910 phase III randomized trial of blinatumomab plus chemotherapy in adults with BCR:ABL-1 negative acute lymphoblastic leukemia. Blood. https://doi.org/10.1182/blood-2025-5120